• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

One Drop launches its diabetes tech in Canada after regulatory nod

November 6, 2017 By Sarah Faulkner

One DropOne Drop announced today that its Bluetooth-enabled blood glucose monitoring system and mobile app are now available throughout Canada after landing approval from the country’s regulatory agency.

The company’s portfolio of diabetes management technology is now available in the U.S., Canada, the E.U. and the United Kingdom.

“In delivering the full One Drop experience to Canada, we are offering an essential extension to the Canadian healthcare system, just as we have in the US, EU, and UK,” founder & CEO Jeff Dachis said in prepared remarks. “You cannot improve health outcomes among people with chronic illness without continuous care. With on-demand advice from diabetes experts and data-driven insights served up every day, we’re delivering hyper-personalized care when and where it’s needed most.”

One Drop’s monthly platform includes a diabetes management mobile app, a glucose monitor and test strips, as well as a coaching service for people with diabetes.

The company sells its products using a direct-to-consumer subscription model. Users can subscribe to gain access to One Drop’s products starting at $19.95 per month, according to the company.

“Any diabetes ‘solution’ must drive positive clinical results,” Dachis added. “With One Drop, we are delivering a well-designed, evidence-based diabetes solution that is accessible, affordable, scalable, and effective to anyone, anywhere in the world. In doing so, we reach our goal of empowering everyone with diabetes to make better choices, lead fuller lives, and achieve meaningful improvements in their health.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Regulatory/Compliance Tagged With: onedrop

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS